您当前的位置: > 详细浏览

Regenerative medicine: targeted genome editing in vivo

请选择邀稿期刊:
摘要: The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.

版本历史

[V1] 2016-05-12 08:40:40 ChinaXiv:201605.01464V1 下载全文
点击下载全文
预览
同行评议状态
待评议
许可声明
metrics指标
  •  点击量3272
  •  下载量1801
评论
分享